what are the reasons that covid 19 has spread across the world
Answers
Answer:
Many health experts believe that the new strain of coronavirus likely originated in bats or pangolins. The first transmission to humans was in Wuhan, China. Since then, the virus has mostly spread through person-to-person contact.
Explanation:
When people with COVID-19 breathe out or cough, they expel tiny droplets that contain the virus. These droplets can enter the mouth or nose of someone without the virus, causing an infection to occur.
The most common way that this illness spreads is through close contact with someone who has the infection. Close contact is within around 6 feet.
The disease is most contagious when a person’s symptoms are at their peak. However it is possible for someone without symptoms to spread the virus. A new study suggests that 10% of infections are from people exhibiting no symptoms.
Droplets containing the virus can also land on nearby surfaces or objects. Other people can pick up the virus by touching these surfaces or objects. Infection is likely if the person then touches their nose, eyes, or mouth.
Answer:
Hey mate, here is your answer.
Explanation:
Rolling updates on coronavirus disease (COVID-19)Updated 17 June 2020
Summary
• A pneumonia of unknown cause detected in Wuhan, China was first reported to the WHO Country Office in China on 31 December 2019.
• WHO is working 24/7 to analyse data, provide advice, coordinate with partners, help countries prepare, increase supplies and manage expert networks.
• The outbreak was declared a Public Health Emergency of International Concern on 30 January 2020.
• On 11 February 2020, WHO announced a name for the new coronavirus disease: COVID-19.
• To stay up to date, follow @DrTedros and @ Hydroxychloroquine arm of Solidarity Trial stops17 June 2020WHO announced that the hydroxychloroquine (HCQ) arm of the Solidarity Trial to find an effective COVID-19 treatment was being stopped.
The trial's Executive Group and principal investigators made the decision based on evidence from the Solidarity trial, UK's Recovery trial and a Cochrane review of other evidence on hydroxychloroquine. Data from Solidarity (including the French Discovery trial data) and the recently announced results from the UK's Recovery trial both showed that hydroxychloroquine does not result in the reduction of mortality of hospitalised COVID-19 patients, when compared with standard of care. Investigators will not randomize further patients to hydroxychloroquine in the Solidarity trial. Patients who have already started hydroxychloroquine but who have not yet finished their course in the trial may complete their course or stop at the discretion of the supervising physician. This decision applies only to the conduct of the Solidarity trial and does not apply to the use or evaluation of hydroxychloroquine in pre or post-exposure prophylaxis in patients exposed to COVID-19.
Thank you
If it is helpful to you, please like it and mark it brainliest, it's my humble request to you.